Analysts consider Ebos’ result a solid one

Analysts consider Ebos’ result a solid one
Jarden analysts have upgraded their rating for Ebos. (Image: Getty)
Ella Somers
Analysts feel upbeat but cautious about the future after healthcare wholesaler Ebos posted a better-than-expected full-year result on Wednesday.Jarden analysts Adrian Allbon and Nick Yeo upgraded their rating from underweight to neutral for the company.“Underlying cashflows were stronger than expected, with a beat on final dividend and lower net debt versus our expectations,” they wrote.Jarden's other highlights for the company included the LifeHealthcare acquisition performing “in line” with management expectations...

More Markets

NZX 50 stumbles as Ebos losses mount
Markets Market Close

NZX 50 stumbles as Ebos losses mount

The NZX 50 has erased Monday's gains. 

Most Asian markets rise on US rate hopes
Markets

Most Asian markets rise on US rate hopes

Investors are awaiting the release of fresh data on prices this week.

AFP 3:18pm
No big NZ cuts amid 'Nuno-geddon': ANZ NZ
Finance

No big NZ cuts amid 'Nuno-geddon': ANZ NZ

ANZ Group chops thousands of staff, contractors, but no big cuts in NZ. 

Vista's new shareholders revealed
Markets

Vista's new shareholders revealed

Flurry of NZX notices show who's been buying Vista shares – and selling too.